Kintara Therapeutics Inc (KTRA): The PPS will rise again. There are NO s...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Kintara Therapeutics Inc (KTRA)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	212
Posts	12762
Boards Moderated	0
Alias Born	12/22/2010

Re: imrichbeotch post# 1166

Friday, 12/02/2022 11:54:10 AM

Friday, December 02, 2022 11:54:10 AM

The PPS will rise again. There are NO shares to short so the NAKED SHORTS will HAVE TO cover the same day or pay for the shares. Would not want to be naked shorting this stock.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KTRA News

Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 08:10:11 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:05:37 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/14/2024 08:55:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:50:14 PM
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/14/2024 08:45:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:40:36 PM
Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 05/13/2024 08:06:50 PM
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement • PR Newswire (US) • 04/03/2024 11:00:00 AM
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab • PR Newswire (US) • 03/27/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:49 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:10 PM
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:07:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:05:27 PM
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer • PR Newswire (US) • 02/12/2024 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:10:10 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/18/2023 09:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 02:10:19 PM
Kintara Therapeutics Announces Review of Strategic Alternatives • PR Newswire (US) • 12/07/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 02:10:08 PM
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement • PR Newswire (US) • 12/05/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 12:55:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:23 PM

More KTRA News

InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow